{"schema":"hottub-news/story/v1","story":"st_bazkqghp5e55gnxgu7zq","title":"Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab","title_en":null,"outlets":4,"brief":null,"page":"https://hottub.news/stories/tiziana-life-sciences-announces-first-participants-dosed-in-als-banyan-bazkqghp5e","count":4,"items":[{"id":"n_bil66py2vrvyexxtwe2a","seq":699971,"kind":"article","title":"Tiziana Life Sciences doses first ALS patients in Phase 2a Foralumab trial","url":"https://www.proactiveinvestors.com/companies/news/1099310/tiziana-life-sciences-doses-first-als-patients-in-phase-2a-foralumab-trial.html","published":"2026-09-29T13:00:00Z","seen":"2026-09-29T14:53:27Z","lang":"en","source":{"id":"proactiveinvestors.com","name":"proactiveinvestors.com","domain":"proactiveinvestors.com"},"via":"gdelt-gkg-english","topics":["health","economy","education","business"],"entities":[{"id":"Q206901","name":"amyotrophic lateral sclerosis","type":"other"}],"story":"st_bazkqghp5e55gnxgu7zq","category":"health","category_p":0.7300000190734863,"sentiment":"positive","tone":0.029999999329447746,"political":0.019999999552965164},{"id":"n_al3tycitdhdr5p7e4gea","seq":497541,"kind":"article","title":"Tiziana Begins Phase 2a BANYAN Trial Of Intranasal Foralumab In ALS Patients","url":"https://www.rttnews.com/3694441/tiziana-begins-phase-2a-banyan-trial-of-intranasal-foralumab-in-als-patients.aspx","published":"2026-09-28T17:40:00Z","seen":"2026-09-28T18:37:37Z","lang":"en","source":{"id":"rttnews.com","name":"rttnews.com","domain":"rttnews.com","outlet":{"wikidata":"Q60748698","name":"RTTNews","type":"news_agency","designations":["news agency","news website"]}},"via":"gdelt-gkg-english","topics":["economy","business","health","education"],"story":"st_bazkqghp5e55gnxgu7zq","category":"health","category_p":0.5600000023841858,"sentiment":"neutral","tone":-0.12999999523162842,"political":0.10000000149011612},{"id":"n_44qm7i5daq5fn76eqfhq","seq":419797,"kind":"article","title":"Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab","url":"https://www.manilatimes.net/2026/09/28/tmt-newswire/globenewswire/tiziana-life-sciences-announces-first-participants-dosed-in-als-banyan-clinical-trial-of-intranasal-foralumab/2434021","published":"2026-09-28T11:08:00Z","seen":"2026-09-28T12:11:22Z","lang":"en","source":{"id":"manilatimes.net","name":"manilatimes.net","domain":"manilatimes.net","outlet":{"wikidata":"Q1573100","name":"The Manila Times","type":"magazine","country":"PH","designations":["organization","periodical"]}},"via":"gdelt-gkg-english","topics":["economy","science","health","education"],"entities":[{"id":"Q5467179","name":"Foralumab","type":"other"}],"story":"st_bazkqghp5e55gnxgu7zq","category":"health","category_p":0.6800000071525574,"sentiment":"neutral","tone":-0.05999999865889549,"political":0.03999999910593033},{"id":"n_bazkqghp5e55gnxgu7zq","seq":408054,"kind":"press_release","title":"Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab","url":"https://www.globenewswire.com/news-release/2026/09/28/3369755/0/en/tiziana-life-sciences-announces-first-participants-dosed-in-als-banyan-clinical-trial-of-intranasal-foralumab.html","summary":"BOSTON, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that the first three participants have all received their first dose of intranasal foralumab in the Phase 2a Healey ALS MyMatch BANYAN clinical trial.","published":"2026-09-28T11:00:00Z","seen":"2026-09-28T11:03:23Z","lang":"en","source":{"id":"globenewswire-public","name":"GlobeNewswire — public companies","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-public","topics":["business","nasdaq:tlsa","us88875g1013"],"story":"st_bazkqghp5e55gnxgu7zq","category":"health","category_p":0.6800000071525574,"sentiment":"neutral","tone":0.20000000298023224,"political":0.03999999910593033}]}